Difficulty: Medium
Average Score: 83%
Practice
Which of the following is the drug of choice in treating suicidal overdose of digitoxin?
Correct answer
A
Rationale
In cases of a suicidal overdose of digitoxin, the drug of choice for treatment is digoxin antibodies (Option A). This is because digoxin antibodies work by binding to the digitoxin, forming a complex that is then excreted by the kidneys, effectively reducing the circulating levels of digitoxin in the body.
Lidocaine (Option B) is a local anesthetic and antiarrhythmic medication used for different conditions such as ventricular arrhythmias, not for digitoxin overdose. Magnesium (Option C) and Potassium (Option D) are important electrolytes for normal body function, but they are not the specific antidotes for digitoxin toxicity.
In an educational context, understanding the specific antidotes for various drug toxicities is crucial for healthcare professionals, especially in emergency situations like drug overdoses. By knowing the correct treatments, healthcare providers can effectively manage and treat patients to prevent severe complications and improve outcomes. This knowledge also highlights the importance of accurate drug administration and monitoring to avoid adverse events and drug interactions.
Lidocaine (Option B) is a local anesthetic and antiarrhythmic medication used for different conditions such as ventricular arrhythmias, not for digitoxin overdose. Magnesium (Option C) and Potassium (Option D) are important electrolytes for normal body function, but they are not the specific antidotes for digitoxin toxicity.
In an educational context, understanding the specific antidotes for various drug toxicities is crucial for healthcare professionals, especially in emergency situations like drug overdoses. By knowing the correct treatments, healthcare providers can effectively manage and treat patients to prevent severe complications and improve outcomes. This knowledge also highlights the importance of accurate drug administration and monitoring to avoid adverse events and drug interactions.